TARGETED MEDICAL PHARMA, INC. (OTCMKTS:TRGM) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On December 6, 2017, Mr. Kim Giffoni tendered his resignation as Interim Chief Executive Officer of Targeted Medical Pharma, Inc. (the “Company”) to focus on other business activities. At the time of his resignation, Mr. Giffoni served as Interim Chief Executive Officer and Director. Mr. Giffoni will remain a member of the Company’s Board and will serve as the Company’s Executive Vice President of Foreign Sales. Mr. Giffoni did not resign as a result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).Emerging growth company ¨If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided to Section 13(a) of the Exchange Act.
An interim Chief Executive Officer, Marcus Charuvastra, the Company’s former VP of Operations and Marketing and a current Director has been appointed by the board.
About TARGETED MEDICAL PHARMA, INC. (OTCMKTS:TRGM)
Targeted Medical Pharma, Inc. (TMP), also doing business as Physician Therapeutics (PTL), is a specialty pharmaceutical company that develops and commercializes amino acid-based medications. The Company develops and distributes a line of amino acid-based medical food products, dietary supplements and generic drugs to physicians, pharmacies and patients throughout the United States and abroad. The Company operates through TMP, Complete Claims Processing Inc. (CCPI) and Amino Nutritionals segments. TMP develops and distributes amino acid-based therapeutic products and distributes pharmaceutical products from other manufacturers. CCPI segment provides point-of-care dispensing solutions, and billing and collections services. Amino Nutritionals segment develops and distributes amino acid-based dietary supplements directly to consumers. Its products and services include Medical Foods, Medical foods and generic pharmaceuticals, and Billing and Collections.